Like Definiens

announced 11/4/2014 via Company Press Release

MedImmunie, Inc., will acquire Definiens

synopsis: AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics, which dramatically improves the identification of biomarkers in tumour tissue.
buyer parent: AstraZeneca
buyer: MedImmunie, Inc.
MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. "
target: Definiens
Definiens is the leading provider of image analysis and data mining solutions for tissue diagnostics and clinical digital pathology. Definiens technology provides detailed cell-by-cell readouts from target structures on tissue slides.
price ($mm)
$150
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/29/2020 via Company Press Release

Ziehm Imaging, acquired THERENVA

synopsis: Germany-based Ziehm Imaging, a developer of mobile X-ray imaging solutions, has acquired Therenva, a leading French developer of planning and imaging software tools for cardiovascular procedures. Ziehm Imaging will leverage its strong distribution network of mobile C-arms to market Therenva’s current product portfolio globally.
buyer: Ziehm Imaging
Germany-based Ziehm Imaging specializes in the development, manufacturing, and worldwide marketing of mobile X-ray-based imaging solutions. The company is the recognized innovation leader in the mobile C-arm industry and a market leader in Germany and other European countries. "
target: THERENVA
France-based Therenva designs the most advanced and user-friendly imaging software toolset for cardiovascular procedures. The unique EndoSize 3D case planning software has become an essential tool in the daily practice of many physicians and healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/20/2019 via BNC Analysis

Circle Cardiovascular Imaging Inc., acquired Corstem

synopsis: Circle Cardiovascular Imaging, a Canadian developer of analytical software for the cardiac imaging community, has acquired Corstem, a Montreal-based machine learning and artificial intelligence software developer focused on cardiac imaging analysis. Corstem offers a suite of solutions that enables better, safer, and faster care decision.​
buyer: Circle Cardiovascular Imaging Inc.
Circle Cardiovascular Imaging is a Canadian developer of analytical software for the cardiac imaging community. Circle's product suite, civ42, is engineered for use in cardiac imaging and has been designed specifically to facilitate efficient quantitative evaluation of cardiac imaging studies. "
target: Corstem
Corstem is a Montreal-based machine learning and artificial intelligence software developer focused on cardiac imaging analysis. Corstem offers a suite of solutions that enables a whole new level of efficiency and automation for diagnosis aid to achieve better, safer, and faster care decision.​
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/6/2018 via BNC Analysis

Philips Electronics NV, will acquire EPD Solutions Ltd.

synopsis: Royal Philips, a global leader in health technology, will acquire EPD Solutions from the Hobart Group, an international portfolio of medical device companies. EPD specializes in making cardiac imaging and navigation systems that help electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
buyer: Philips Electronics NV (ENXTAM:PHIA:$22,796.71)
Based in the Netherlands, Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. "
target parent: Hobart Group (Medical Device)
target: EPD Solutions Ltd.
EPD Solutions (EPD) is dedicated to improving the efficiency of minimally invasive catheter-based procedures performed to treat cardiac arrhythmias. EPD's cardiac imaging and navigation system helps electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
price ($mm)
$292
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/15/2017 via PE Hub

Imagia, acquired Cadens Medical Imaging

synopsis: Imagia, a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems, announced the completion of its acquisition of Cadens Medical Imaging (Cadens), a technology leader in medical imaging software.
buyer: Imagia
Imagia is a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems. "
target: Cadens Medical Imaging
Cadens Medical Imaging (Cadens) is a technology leader in medical imaging software. Since 2008, Cadens has developed and marketed FDA and CE cleared innovative medical imaging software products for cancer care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/11/2016 via BNC Analysis

Stryker Corporation, acquired imorphics

synopsis: Stryker Corporation has acquired Imorphics, Ltd. Imorphics was initially a spin out from the world renowned Computer Imaging Department of Manchester University. Its product, EndPoint, is a software environment in which the user can build and use statistical models, as well as view images and perform analysis tasks, such as manual segmentation.
buyer: Stryker Corporation (SYK:$16,669.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
target: imorphics
Imorphics, Ltd. provides medical image analysis software tools. Its projects include work on diseases of the musculoskeletal system, the central nervous system, and oncology. The company’s technology is used in clinical trials, and in both clinical and animal research projects.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/13/2015 via BusinessWire

Toshiba Medical Systems Corporation, acquired Olea Medical

synopsis: Olea Medical SA, a company that designs and markets innovative medical imaging applications, has been acquired by Toshiba Medical Systems Corporation, a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions.
buyer parent: Toshiba
buyer: Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. "
target: Olea Medical
Olea Medical™ designs and markets innovative medical imaging applications that significantly improve diagnostic processes and treatment evaluation. They are based in France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/9/2022 via PR Newswire

Mentice AB, will acquire Ankyras

synopsis: Mentice, a world leader in medical simulation solutions, will acquire Ankyras from Galgo Medical, a medical imaging software company in Spain. Ankyras is a Spanish software solution that reveals braided stent behavior. Ankyras enables users to create personalized predictive simulations of braided stents in the treatment of Intracranial aneurysms.
buyer: Mentice AB (OM:MNTC:$18.15)
Sweden-based Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. The company's solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. "
target parent: Galgo Medical S.L.
target: Ankyras
Ankyras is a Spanish software solution that reveals braided stent behavior. Ankyras enables users to create personalized predictive simulations of braided stents in the treatment of Intracranial aneurysms for precise and safe implantation.
price ($mm)
$2.96
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/20/2021 via GlobeNewswire

SeaSpine, acquired 7D Surgical

synopsis: SeaSpine, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, has acquired 7D Surgical, a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care.
buyer: SeaSpine (SPNE:$160.19)
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. "
target: 7D Surgical
7D Surgical is a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care.
price ($mm)
$110
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/20/2022 via PR Newswire

Blackrock Neurotech, acquired Mind-X Corp

synopsis: Blackrock Neurotech, a leading implantable brain-computer interface ("BCI") technology, announced the acquisition of spatial computing software firm MindX, integrating the Company's innovative augmented reality ("AR") and artificial intelligence ("AI") technology with Blackrock's BCI hardware.
buyer: Blackrock Neurotech
Blackrock Neurotech is dedicated to the clinical translation of brain-computer interface (BCI) technology. Blackrock, founded in 2008, is the world's leading platform company for BCI technology and the development of implantable solutions that improve human lives. "
target: Mind-X Corp
MindX has developed an innovative software platform, MindOS, that utilizes brain-computer interfaces for next-generation spatial computing applications in assistive medical devices and consumer electronics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2019 via BNC Analysis

MicroSurgical Technology, Inc., acquired Neomedix Corporation

synopsis: In a move to expand its offerings into surgical glaucoma, MST has acquired the assets of NeoMedix Corporation related to glaucoma, including Trabectome and Goniotome product platforms. Trabectome is an easy to use surgical technology used to treat glaucoma, and Goniotome is an innovative solution for goniotomy
buyer parent: Halma plc
buyer: MicroSurgical Technology, Inc.
MicroSurgical Technology (MST) manufactures ophthalmic surgical products, focusing on single-use devices used in cataract surgery. MST makes precise, small tools that allow the management of delicate eye tissue or fluid. "
target: Neomedix Corporation
NeoMedix Corporation develops software and is known for its Trabectome and Goniotome products. Trabectome is an easy to use surgical technology with a clinical history of proven efficacy used to treat glaucoma. Goniotome is an easy and innovative solution for goniotomy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2014 via Company Press Release

Materialise Dental N.V., acquired OrthoView

synopsis: Materialise announced the acquisition of UK-based OrthoView Holdings Limited, the world's leading provider of 2D digital pre-operative planning and templating solutions for orthopedic surgeons. OrthoView’s software imports a digital X-ray image from a PACS and positions the templates of suitable prostheses on the X-ray image at the correct scale.
buyer: Materialise Dental N.V. (GS:MTLS:$204.45)
Materialise Dental offers planning and simulation software tools under the SimPlant brand. These tools enable implantologists and oral surgeons to scientifically plan dental implant surgery on an interactive basis. "
target: OrthoView
OrthoView enables orthopedists to create detailed pre-operative plans quickly and easily from digital x-ray images. The OrthoView solution provides an easy to use method of planning and templating with digital x-ray images, incorporating specialist on-screen measuring tools and patented wizards.
price ($mm)
$14
rev ($mm)
$6
EBITDA ($mm)
$2
EV / rev
2.6x
EV / EBITDA
9.3x
closed 8/5/2014 via PR Newswire

Varian Medical Systems, Inc., purchased Radiation Simulation Software from Transpire, Inc.

synopsis: Varian Medical Systems, Inc., announced it has acquired certain assets of Transpire, Inc., including the Acuros® dose calculation software that has been integrated into Varian's market-leading BrachyVision™ and Eclipse™ treatment planning software products. The acquisition also covers Transpire's Attila™ software.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. "
seller: Transpire, Inc.
Transpire develops advanced simulation software products that accurately and rapidly predict the macroscopic behavior of radiation. Their software includes the Attila™ software, used in industries where radiation effects play a role in product performance, and the Acuros® dose calculation software.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/3/2019 via BNC Analysis

Surgical Science, acquired SenseGraphics

synopsis: Surgical Science Sweden AB, a Swedish supplier of virtual reality simulators for medical training, has acquired SenseGraphics AB, a Sweden-based medical simulator software developer. SenseGraphics develops medical simulators that combine the latest technologies to provide surgeons with an experience that is as close to reality as possible.
buyer: Surgical Science (OM:SUS:$7.20)
Surgical Science is a Swedish supplier of virtual reality simulators for medical training. Their training systems for laparoscopy and endoscopy are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors. "
target: SenseGraphics
SenseGraphics is a Sweden-based medical simulator software developer. SenseGraphics develops next generation medical simulators for a wide range of surgical procedures. Their simulators combine the latest technologies to provide surgeons with an experience that is as close to reality as possible.
price ($mm)
$32
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/23/2018 via BusinessWire

TransEnterix, Inc., acquired MST Medical Surgery Technologies Ltd.

synopsis: TransEnterix, a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, has acquired MST Medical Surgery Technologies Ltd. (MST), an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment.
buyer: TransEnterix, Inc. (AMEX:TRXC:$14.74)
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery. Their Senhance Surgical Robotic System is a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology. "
target: MST Medical Surgery Technologies Ltd.
MST Medical Surgery Technologies Ltd. (MST) is an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery (MRCAS).
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/13/2018 via GlobeNewswire

Globus Medical, acquired Surgimap

synopsis: Globus Medical, Inc., a leading musculoskeletal solutions company, announced the acquisition of Nemaris Inc., a privately held company that markets and develops Surgimap®, a leading surgical planning software platform.
buyer: Globus Medical (GMED:$675.57)
Globus Medical, Inc. is a leading medical device manufacturer and is driving significant technological advancements across a complete suite of spinal products. "
target: Surgimap
Nemaris Inc. is a privately held company that markets and develops Surgimap®, a leading surgical planning software platform. Surgimap® allows healthcare professionals to simulate potential surgical outcomes and share medical imaging globally to improve procedural workflow and patient care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/19/2017 via Company Press Release

JSR Corporation, will acquire Lexi Co., Ltd.

synopsis: JSR Corporation agreed to acquire Lexi Co., Ltd., a medical 3D software company. Lexi Co., Ltd. develops 3D medical pre-operative planning software. Its ZedHip, ZedKnee and JIGEN software can create 3D models of the bone using CT data.
buyer: JSR Corporation (TSE:4185:$3,499.68)
JSR Corporation, based in Japan, was established in 1957 for domestic production of synthetic rubbers. Since then, JSR has continuously expanded its business to emulsions, plastics and other materials for the semiconductor, flat panel display, and optical materials fields. "
target: Lexi Co., Ltd.
Lexi is a Japanese company that develops 3D medical pre-operative planning software. Its ZedHip, ZedKnee and JIGEN software can create 3D models of the bone using CT data. Users can perform surgical simulations (such as positioning of implants, calculation of parameters, etc.) in simple steps.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2014 via GlobeNewswire

3D Systems Corporation, acquired Simbionix USA Corporation

synopsis: 3D Systems announced that it completed the acquisition of Simbionix, the global leader in 3D virtual reality surgical simulation and training for $120 million in cash. Simbionix USA Corporation is the world's leading provider of 3D simulation and training products for medical professionals and the healthcare industry.
buyer: 3D Systems Corporation (DDD:$617.50)
3D Systems is a leading provider of 3D printing centric design-to-manufacturing solutions including 3D printers, print materials and cloud sourced on-demand custom parts for professionals and consumers alike in materials including plastics, metals, ceramics and edibles. "
target: Simbionix USA Corporation
Simbionix USA Corporation is the world's leading provider of 3D simulation and training products for medical professionals and the healthcare industry. The company is committed to delivering the highest quality products, advancing clinical performance and optimizing procedural outcomes.
price ($mm)
$120
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2012 via PR Web

Visualization Sciences Group, acquired Amira

synopsis: Visage Imaging, Inc. announced they have signed a definitive agreement completing the sale of the Amira Division to Visualization Sciences Group. Amira is a powerful, multifaceted software platform for visualizing, manipulating, and understanding Life Science and bio-medical data coming from all types of sources and modalities.
buyer parent: FEI
buyer: Visualization Sciences Group
Visualization Sciences Group is the leading provider of high-performance 3D visualization toolkits and software for engineers and scientists, delivering advanced 3D software solutions for scientific data visualization, engineering and simulation, materials science and geosciences. "
target parent: Pro Medicus
target: Amira
Amira is a powerful, multifaceted software platform for visualizing, manipulating, and understanding Life Science and bio-medical data coming from all types of sources and modalities.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/9/2019 via PE Hub

Micromed SpA, acquired OSG bvba

synopsis: Micromed, an Italian medical device company, has acquired OSG BVBA, a Belgium-based sleep diagnostics software company strongly positioned in sleep neuromonitoring and clinical neurophysiology. With the acquisition, Micromed will gain direct access to the Benelux market, thanks to OSG’s strong position in the area.
buyer parent: ArchiMed
buyer: Micromed SpA
Micromed is an Italian medical device company delivering solutions in Neurophysiology worldwide. Partnering with hospitals, sleep labs, and research centers on a global scale, Micromed manufactures and markets neurodiagnostic hardware and software to neurologists, clinicians and researchers. "
target: OSG bvba
OSG is a Belgian developer of software products for Sleep Research and Brain Research. With their products BrainRT and SleeptRT, OSG is highly regarded in sleep neuromonitoring and clinical neurophysiology with advanced capabilities in AI as it relates to sleep scoring and data interpretation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2014 via Company Press Release

MedImmunie, Inc., will acquire Definiens

synopsis: AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics, which dramatically improves the identification of biomarkers in tumour tissue.
buyer parent: AstraZeneca
buyer: MedImmunie, Inc.
MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. "
target: Definiens
Definiens is the leading provider of image analysis and data mining solutions for tissue diagnostics and clinical digital pathology. Definiens technology provides detailed cell-by-cell readouts from target structures on tissue slides.
price ($mm)
$150
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2010 via PR Newswire

Trimble Navigation Limited, acquired eCognition

synopsis: Trimble and Definiens, a company specializing in image analysis solutions, announced Trimble's acquisition of Definiens' Earth Sciences business assets, eCognition® software, an advanced image analysis software suite for geospatial applications that facilitates fast and accurate geo-information extraction from remote sensing imagery.
buyer: Trimble Navigation Limited (TRMB:$3,659.10)
Trimble applies technology to make field and mobile workers in businesses and government significantly more productive. Solutions are focused on applications requiring position or location—including surveying, construction, agriculture, fleet and asset management, public safety and mapping. "
target parent: Definiens
target: eCognition
eCognition software enables organizations to quickly extract accurate geo-information from any kind of remote sensing data. The software assists data providers, value adders and scientist in integrating earth observation and remote sensing data to generate accurate GIS-ready information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2014 via Company Press Release

MedImmunie, Inc., will acquire Definiens

synopsis: AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics, which dramatically improves the identification of biomarkers in tumour tissue.
buyer parent: AstraZeneca
buyer: MedImmunie, Inc.
MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. "
target: Definiens
Definiens is the leading provider of image analysis and data mining solutions for tissue diagnostics and clinical digital pathology. Definiens technology provides detailed cell-by-cell readouts from target structures on tissue slides.
price ($mm)
$150
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/28/2022 via BNC Analysis

Cosmos Holdings Inc., will acquire ZipDoctor, Inc

synopsis: Cosmos Holdings, a global healthcare group, will acquire ZipDoctor Inc. from American International Holdings Corp (AMIH). ZipDoctor Inc. is a direct-to-consumer subscription-based telemedicine platform that provides customers affordable, 24/7 access to board certified physicians and licensed mental and behavioral health counselors and therapists.
buyer: Cosmos Holdings Inc. (COSM:$56.24)
Cosmos Holdings is a global healthcare group that was incorporated in 2009 and is headquartered in Chicago, Illinois. Cosmos Health is engaged in the nutraceuticals sector through its own proprietary lines of products "Sky Premium Life" and "Mediterranation." "
target parent: American International Holdings Corp.
target: ZipDoctor, Inc
ZipDoctor is a direct-to-consumer subscription-based telemedicine platform that provides customers with affordable, unlimited, 24/7 access to board certified physicians and licensed mental and behavioral health counselors and therapists.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/7/2022 via BNC Analysis

PanGenomic Health Inc., will acquire Mindleap Health

synopsis: PanGenomic Health Inc., a digital health platform in Canada, will acquire Mindleap Health Inc. from Mydecine Innovations Group Inc., a biotechnology company. Mindleap is a telehealth solution that helps people connect with mental health specialists. The app helps people to sleep better, feel safe, and understand psychedelic experiences.
buyer: PanGenomic Health Inc. (CNSX:NARA:$0.00)
PanGenomic is a digital health platform in Canada. PanGenomic provides people with personal control over their mental health treatments. Their Nara solution is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness. "
target parent: Mydecine
target: Mindleap Health
Mindleap is a telehealth solution that helps people connect with mental health specialists. Mindleap helps people to sleep better, feel safe, and understand psychedelic experiences. The app allows users to talk to specialists that break down information into useful and digestible segments.
price ($mm)
$3.08
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2022 via BNC Analysis

MediBuddy, acquired Clinix

synopsis: MediBuddy, India’s largest and most trusted digital healthcare platform, has acquired Clinix, an online doctor consultation platform in India. Clinix connects households to doctors to make healthcare more accessible. Their app allows users to book appointments within minutes and securely talk to their doctor via text chat, audio, or video calls.
buyer: MediBuddy
MediBuddy is India’s largest and most trusted digital healthcare platform. MediBuddy enables people to book health checks, lab tests, online consultations, order medication, and more. Their platform offers a network of 90,000 doctors, 7,000 hospitals, and,3,000 diagnostic centres in India. "
target: Clinix
Clinix an online doctor consultation platform in India. Clinix connects households to doctors to make healthcare more accessible. Their app allows users to book appointments within minutes and securely talk to their doctor via text chat, audio, or video calls.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/15/2022 via BusinessWire

One80 Intermediaries, acquired 1.800MD

synopsis: One80 Intermediaries, a specialty insurance broker, has acquired 1.800MD and Imhealthytoday. 1.800MD provides specialized telemedicine services for individuals, families, employers, and groups. Imhealthytoday (IHT) is a virus intelligence platform created in 2020 to address COVID‐19 health and safety issues facing large employers and schools.
buyer: One80 Intermediaries
One80 Intermediaries is a highly focused wholesale brokerage and program manager providing specialized insurance solutions throughout the US and Canada. "
target: 1.800MD
1.800MD provides specialized telemedicine services for individuals, families, employers, and groups. Imhealthytoday (IHT) is a virus intelligence platform created in 2020 to address COVID‐19 health and safety issues facing large employers and schools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/20/2022 via PR Newswire

Quip NYC, Inc., acquired Toothpic App

synopsis: quip has acquired Toothpic, a leading telehealth company offering teledental services and care to more than 36 million Americans through partnerships with premier dental insurers. The acquisition makes quip the first oral care company to connect at-home oral care products with preventative telehealth services and professional dental care.
buyer: Quip NYC, Inc.
quip is a modern oral health company that provides thoughtfully designed personal oral care products and professional dental care services through a digital platform that makes oral care more simple, accessible, and enjoyable. "
target: Toothpic App
Toothpic is a leading smart dental technology company on a mission to radically transform people's oral health. Toothpic leverages technology, data and insights to deliver better care, better outcomes and a more personalized experience.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/13/2022 via BNC Analysis

Gympass, acquired Vitalk

synopsis: Gympass, the corporate wellness unicorn, has announced the purchase of Vitalk, a São Paulo-based healthtech active in the corporate mental health prevention and training space. Founded by US entrepreneur Michael Kapps in 2019, Vitalk ended 2021 with a positive performance in Brazil, surpassing 220,000 individuals covered.
buyer: Gympass
Gympass is a discovery platform that empowers companies to engage their workforce in physical activity by providing access to the largest global network of workout facilities. Gympass is currently active across 14 countries and boasts more than 2,000 clients and over 50,000 gym or studio partners. "
target: Vitalk
Vitalk is a São Paulo-based healthtech active in the corporate mental health prevention and training space. Founded by US entrepreneur Michael Kapps in 2019, Vitalk ended 2021 with a positive performance in Brazil, surpassing 220,000 individuals covered.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/4/2022 via BusinessWire

Recuro Health, Inc., acquired WellVia

synopsis: Recuro Health, an integrated digital health solutions company providing personalized benefits through its Digital Medical Home™, has acquired WellVia, a premier virtual health provider that remotely connects patients to board-certified physicians and behavioral health specialists.
buyer: Recuro Health, Inc.
Recuro Health delivers value throughout the healthcare ecosystem with digital solutions that respond to ongoing changes in the health care system. Recuro's holistic, integrated, and interoperable solutions create a personalized digital medical home that results in better outcomes and lower costs. "
target: WellVia
WellVia is a premier tech enabled virtual healthcare services company providing comprehensive and integrated healthcare solutions via its technology platform. WellVia provides access to virtual medical, behavioral health, and specialist care via telephone, secure video or the WellVia Mobile App.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/9/2022 via Company Press Release

Doktor.se, acquired Kollarna.se

synopsis: Doktor.se, one of Sweden's largest company in digiphysical care, has acquired Kollarna.se, a provider of online diagnosis services in Sweden. Kollarna.se enables patients to get diagnosed by a doctor without visiting a primary care center. They offer services for acne, urinary tract infection, Lyme disease, herpes, allergies, and more.
buyer: Doktor.se
Doktor.se is one of Sweden's largest company in digiphysical care. Doktor.se owns 15 physical health centres in Sweden with approximately 160,000 listed patients. They also provide services to patients worldwide through their mobile app. "
target: Kollarna.se
Kollarna.se is a provider of online diagnosis services in Sweden. Kollarna.se enables patients to get diagnosed by a doctor without visiting a primary care center. They offer services for acne, urinary tract infection, Lyme disease, herpes, allergies, inflammation and menstruation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/23/2022 via Company Press Release

Potomac Equity Partners, acquired U.S. Mobile Health Exams, Inc.

synopsis: Potomac Equity Partners, LLC, a Washington, D.C.-based investment firm, announced the acquisition of U.S. Mobile Health Exams, a leading provider of mobile health testing and examination services. U.S. Mobile Health Exams specializes in occupational health tests and health screenings.
buyer: Potomac Equity Partners
Potomac Equity Partners is a Washington, D.C.-based private equity investment firm focused on providing superior equity returns through the close partnership and collaboration with its portfolio company management team members. "
target: U.S. Mobile Health Exams, Inc.
Founded in 2011 and headquartered in Jacksonville, FL, U.S. Mobile Health Exams is a leading mobile health testing provider specializing in occupational health tests, and health screenings. The Company performs on-site health services for customers across the U.S. and in a broad range of industries
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/10/2022 via BNC Analysis

Nurx will be merged with Thirty Madison,

synopsis: Nurx and Thirty Madison, both of which provide specialized telehealth options, announced that they've entered into a definitive agreement to merge into a combined company under the Thirty Madison brand. Through the Nurx website and mobile app, users can get a prescription from a doctor and have their medication delivered right to their door.
buyer: Thirty Madison
Thirty Madison is the premier healthcare company for people living with chronic conditions. Their offerings include: Keeps, a men’s hair loss solution; Cove, which focuses on migraine; Evens, which treats acid reflux; and Picnic, which targets allergic rhinitis. "
target: Nurx
At Nurx, they are making healthcare more accessible to everyone from the comfort of their home. Through their website and mobile app, users can get a prescription from a doctor and have their medication delivered right to their door.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2022 via BNC Analysis

Dr.Dropin, acquired Snapmed AS

synopsis: Dr.Dropin, an accessible and modern private health service that offers the vast majority of medical services at a fixed price, has acquired Snapmed, a global online dermatology service based in Norway.
buyer: Dr.Dropin
Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price. They are based in Norway. "
target: Snapmed AS
Snapmed is a global online dermatology service. They give everyone access to secure and high-quality skin care advice at unmatched convenience and affordability. They are based in Norway.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2022 via BNC Analysis

Health Connect America, acquired Georgia HOPE

synopsis: Health Connect America has acquired Georgia HOPE (Family and Children First, LLC). Based in Dalton, Georgia, Georgia HOPE (Family and Children First, LLC) provides mental health therapy, family preservation/reunification, and substance use disorder treatment.
buyer parent: Palladium Equity Partners LLC
buyer: Health Connect America
Health Connect America provides mental and behavioral health services to children, families, and adults across multiple states. Health Connect America is honored to be a part of the communities it serves and walk alongside its clients as they embark on a journey to self-improvement. "
target: Georgia HOPE
Based in Dalton, Georgia, Georgia HOPE (Family and Children First, LLC) provides mental health therapy, family preservation/reunification, and substance use disorder treatment. Georgia HOPE has provided its services in the state of Georgia for over 20 years.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2022 via BNC Analysis

Health Connect America, acquired Pinnacle Family Services

synopsis: Health Connect America has acquired Pinnacle Family Services Holdings. Pinnacle Family Services, headquartered in Raleigh, provides therapeutic foster care and periodic behavioral health services at home to youth.
buyer parent: Palladium Equity Partners LLC
buyer: Health Connect America
Health Connect America provides mental and behavioral health services to children, families, and adults across multiple states. Health Connect America is honored to be a part of the communities it serves and walk alongside its clients as they embark on a journey to self-improvement. "
target: Pinnacle Family Services
Raleigh-based Pinnacle Family Services is a leading provider of home- and community-based services and programs for at-risk youth and their families. Their programs include therapeutic foster care for mental health, dual diagnoses, and medically complex individuals, family preservation, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2022 via BNC Analysis

Health Connect America, acquired HEADS

synopsis: Health Connect America has acquired HEADS (Healing Educational Alternatives for Deserving Students). Based in Plant City, Florida, HEADS provides trauma treatment to children and families. They have been committed to helping children and their families in Florida since 1992.
buyer parent: Palladium Equity Partners LLC
buyer: Health Connect America
Health Connect America provides mental and behavioral health services to children, families, and adults across multiple states. Health Connect America is honored to be a part of the communities it serves and walk alongside its clients as they embark on a journey to self-improvement. "
target: HEADS
Based in Plant City, Florida, HEADS (Healing Educational Alternatives for Deserving Students) provides trauma treatment to children and families. They have been committed to helping children and their families in Florida since 1992.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/14/2022 via PR Newswire

New Directions Behavioral Health, acquired Tridiuum

synopsis: New Directions Behavioral Health, a provider of comprehensive behavioral health solutions, has acquired Tridiuum, a digital behavioral health company. Tridiuum accelerates patient access to the most appropriate care by automating behavioral health screening, triaging, matching and online scheduling through its easy-to-use system.
buyer: New Directions Behavioral Health
New Directions improves access to quality behavioral healthcare through a comprehensive suite of coordinated behavioral health services. The company supports over 15 million individuals nationally, in partnership with health plans, employers and higher education institutions. "
target: Tridiuum
Tridiuum is a digital behavioral health company and network management partner that bridges the gap between patients, payers, and providers to improve access and follow-up care. The company's Tridiuum ONE platform powers behavioral health operations and workflows to advance patient outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/13/2022 via GlobeNewswire

LifeMD, Inc., acquired Cleared

synopsis: LifeMD, Inc., a leading direct-to-patient telehealth company, announced it has acquired Cleared, a direct-to-consumer telehealth destination that provides end-to-end personalized care for allergy, asthma and immunology.
buyer: LifeMD, Inc. (K:CVLB:$78.35)
LifeMD, Inc. (formerly Conversion Labs) is a rapidly growing direct-to-patient telehealth company that offers cash-pay virtual medical care across all 50 states. LifeMD’s telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers. "
target: Cleared
Cleared is a direct-to-consumer telehealth destination that provides end-to-end personalized care for allergy, asthma and immunology.
price ($mm)
$4.43
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/14/2022 via GlobeNewswire

CloudMD Software & Services Inc., acquired MindBeacon

synopsis: Canada-based CloudMD Software & Services Inc. has acquired MindBeacon Holdings Inc., a leading Canadian digital mental healthcare platform that provides a continuum of care, focusing on internet-based Cognitive Behavioural Therapy (iCBT), which is an effective therapy provided through a computer or a mobile device.
buyer: CloudMD Software & Services Inc. (CNSX:PHGI:$55.36)
Based in Canada, CloudMD is digitizing the delivery of healthcare by providing a patient centric approach, with an emphasis on continuity of care. The company offers SAAS based health technology solutions to healthcare providers across North America. "
target: MindBeacon (TSX:MBCN:$15.71)
Based in Toronto, MindBeacon provides a continuum of mental healthcare that includes self-guided psychoeducational and wellness content, peer-to-peer support, therapist guided programs, and live therapy sessions all offered virtually through its secure and private platform.
price ($mm)[EV]
$92 [$51]
rev ($mm)
$16
EBITDA ($mm)
EV / rev
3.3x
EV / EBITDA
closed 11/1/2021 via GlobeNewswire

23andMe, Inc., acquired Lemonaid Health

synopsis: 23andMe Holding Co., a leading consumer genetics and research company, announced that it has completed its previously-announced acquisition of Lemonaid Health, Inc., an on-demand platform for accessing medical care and pharmacy services online.
buyer: 23andMe, Inc. (ME:$255.10)
23andMe, Inc. is a leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company was founded in 2006 and is based in Mountain View, California. "
target: Lemonaid Health
Lemonaid Health is a leading innovator in telemedicine and prescription drug delivery. The Lemonaid Health platform leverages clinical algorithms to augment its experienced medical providers’ knowledge base, enabling patients to quickly, safely and inexpensively get care and prescriptions.
price ($mm)
$400
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2021 via BusinessWire

Oak Street Health, Inc., acquired RubiconMD Inc.

synopsis: Oak Street Health, Inc. has acquired RubiconMD, the leading technology platform providing access to specialist expertise. The deal enables Oak Street Health to integrate virtual specialty care into its existing care model, which significantly streamlines the referral process and better manages costs while also enhancing the patient experience.
buyer: Oak Street Health, Inc. (OSH:$1,116.37)
Oak Street Health is a network of value-based primary care centers for adults on Medicare. The company operates an innovative healthcare model focused on quality of care over volume of services, and assumes the full financial risk of its patients. "
target: RubiconMD Inc.
RubiconMD advances its mission to democratize medical expertise by connecting primary care clinicians to top specialists. Through its digital platform, RubiconMD enables the remote exchange of insights between clinicians, reduces patient wait time and travel burdens, and more.
price ($mm)
$130
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2021 via GlobeNewswire

Syneos Health, acquired StudyKIK

synopsis: Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the acquisition of StudyKIK, a leading technology-enabled clinical trial recruitment and retention company.
buyer: Syneos Health (INCR:$5,418.61)
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Their company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. "
target: StudyKIK
StudyKIK is a leading technology-enabled clinical trial recruitment and retention company. StudyKIK supports patient recruitment, patient retention, eConsent Solutions, Telemedicine Video Calling, and study companion mobile applications to expedite clinical trials
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Definiens


read more

Definiens

THERENVA

Corstem

EPD Solutions Ltd.

Cadens Medical Imaging

imorphics

Olea Medical

Ankyras

7D Surgical

Mind-X Corp

Neomedix Corporation

OrthoView

Transpire, Inc.

SenseGraphics

MST Medical Surgery Technologies Ltd.

Surgimap

Lexi Co., Ltd.

Simbionix USA Corporation

Amira

OSG bvba

read more

Definiens

eCognition

read more

Definiens

read more

ZipDoctor, Inc

Mindleap Health

Clinix

1.800MD

Toothpic App

Vitalk

WellVia

Kollarna.se

U.S. Mobile Health Exams, Inc.

Nurx

Snapmed AS

Georgia HOPE

Pinnacle Family Services

HEADS

Tridiuum

Cleared

MindBeacon

Lemonaid Health

RubiconMD Inc.

StudyKIK

Geography
Matching Companies
Ticker: STO:SECTB
 
 
 
 
 
 
 
 
Sectra AB
Sectra AB
Sectra successfully develops and sells cutting edge solutions and services within the niches medical IT and secure communication. The company’s products are used by customers in 50 countries and sales are conducted directly by Sectra as well as through regional partners.
year
2015
rev ($mm)
$121.11
EBITDA ($mm)
$19.82
EBIT ($mm)
$16.26
Net Income ($mm)
$13.69
Employees
603
  • drill down
  • watch
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: ASX:VRI
 
 
 
 
 
 
 
 
Echo IQ
Echo IQ
Echo IQ is an Australian software company that is reinventing cardiac diagnostics. Echo IQ uses its AI-driven technology to enhance the diagnosis of structural heart disease. Their solutions use advanced data science and cardiac data to improve risk detection for often-treatable conditions.
year
2019
rev ($mm)
$0.58
EBITDA ($mm)
($0.24)
EBIT ($mm)
($0.24)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ASX:RAP
 
 
 
 
 
 
 
 
ResApp Health
ResApp Health
ResApp Health is a mobile telehealth solution based in Australia. ResApp Health assists doctors and empowers patients to diagnose and manage respiratory disease. Their solution allows doctors to instantly diagnose respiratory diseases from the sound of their patient’s cough or breathing.
year
2021
rev ($mm)
$0.05
EBITDA ($mm)
($4.93)
EBIT ($mm)
($5.04)
Net Income ($mm)
Employees
510
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: TSE:4543
 
 
 
 
 
 
 
 
Terumo Corporation
Terumo Corporation
Terumo is a global leader in medical technology. The company's business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems and diabetes care.
year
2020
rev ($mm)
$5,694.98
EBITDA ($mm)
$1,437.51
EBIT ($mm)
$927.04
Net Income ($mm)
$721.22
Employees
26438
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$34.31
EBITDA ($mm)
$3.97
EBIT ($mm)
($2.02)
Net Income ($mm)
Employees
282
  • drill down
  • watch
Ticker: NMXS
 
 
 
 
 
 
 
 
Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc.
Net Medical Xpress is a medical services company that provides clinical and diagnostic programs using advanced telemedicine solutions for hospitals. The company also develops FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments.
year
2011
rev ($mm)
$3.21
EBITDA ($mm)
($0.20)
EBIT ($mm)
($0.21)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OM:EKTA B
 
 
 
 
 
 
 
 
Elekta AB
Elekta AB
Elekta is pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops state-of-the-art tools and treatment-planning systems for radiation therapy, as well as workflow-enhancing software systems across the spectrum of cancer care.
year
2020
rev ($mm)
$1,523.59
EBITDA ($mm)
$230.61
EBIT ($mm)
$200.20
Net Income ($mm)
$125.79
Employees
4000
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: KOSDAQ:A263700
 
 
 
 
 
 
 
 
Carelabs Co., Ltd.
Carelabs Co., Ltd.
Carelabs is a South Korea-based digital beauty and healthcare company. CareLabs provides comprehensive healthcare IT services, including clinic information services, clinic customer management software, and digital marketing solutions.
year
2019
rev ($mm)
$49.51
EBITDA ($mm)
$4.38
EBIT ($mm)
$3.14
Net Income ($mm)
$1.79
Employees
0
  • drill down
  • watch
Ticker: CERN
 
 
 
 
 
 
 
 
Cerner Corporation
Cerner Corporation
Cerner's health information technologies connect people, information, and systems. Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations.
year
2021
rev ($mm)
$5,707.53
EBITDA ($mm)
$1,462.77
EBIT ($mm)
$1,008.36
Net Income ($mm)
$522.26
Employees
26400
  • drill down
  • watch
Ticker: DXCM
 
 
 
 
 
 
 
 
Dexcom, Inc.
Dexcom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare providers.
year
2018
rev ($mm)
$832.50
EBITDA ($mm)
($2.90)
EBIT ($mm)
($24.10)
Net Income ($mm)
Employees
2290
  • drill down
  • watch
Ticker: 300253
 
 
 
 
 
 
 
 
Shanghai Kingstar Winning Software Co., Ltd.
Shanghai Kingstar Winning Software is principally engaged in the development of medical software, the provision of technology services and the distribution of hardware products. They primarily offer software, including hospital information systems and public health information management systems.
year
2015
rev ($mm)
$98.42
EBITDA ($mm)
$14.01
EBIT ($mm)
$12.72
Net Income ($mm)
$21.57
Employees
454
  • drill down
  • watch
Ticker: ICAD
 
 
 
 
 
 
 
 
iCAD, Inc.
iCAD, Inc.
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster. iCAD offers a range of computer aided detection (CAD) solutions to support rapid detection of breast, prostate and colorectal cancers.
year
2015
rev ($mm)
$47.24
EBITDA ($mm)
$5.53
EBIT ($mm)
$1.33
Net Income ($mm)
Employees
143
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Novartis AG
Novartis AG
Novartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales. Their focus is on cancer, immunology, dermatology, cardiovascular, renal and more.
year
2019
rev ($mm)
$48,677.00
EBITDA ($mm)
$15,532.00
EBIT ($mm)
$11,351.00
Net Income ($mm)
$11,732.00
Employees
103914
  • drill down
  • watch
Ticker: LSE:AZN
 
 
 
 
 
 
 
 
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines.
year
2021
rev ($mm)
$37,417.00
EBITDA ($mm)
$8,373.00
EBIT ($mm)
$4,569.00
Net Income ($mm)
$112.00
Employees
83100
  • drill down
  • watch
Ticker: OTCPK:PRLX
 
 
 
 
 
 
 
 
Parallax Health Sciences, Inc.
Parallax Health Sciences, Inc. is an innovative biomedical healthcare company delivering consumer-centric products and services in the areas of pharmaceuticals, digital health and remote patient monitoring, behavioral health and point of care diagnostics.
year
2016
rev ($mm)
$18.98
EBITDA ($mm)
($1.31)
EBIT ($mm)
($1.43)
Net Income ($mm)
Employees
34
  • drill down
  • watch
Ticker: RVNC
 
 
 
 
 
 
 
 
Revance Therapeutics, Inc.
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection.
year
2020
rev ($mm)
$0.19
EBITDA ($mm)
($185.77)
EBIT ($mm)
($188.79)
Net Income ($mm)
Employees
193
  • drill down
  • watch
Ticker: CNSX:NF
 
 
 
 
 
 
 
 
Mydecine
Mydecine
Mydecine is a biotechnology company. Mydecine is developing the next generation of innovative medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder. They aim to provide patients with safer and more effective treatment solutions.
year
2019
rev ($mm)
$0.18
EBITDA ($mm)
($3.31)
EBIT ($mm)
($3.35)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ABC
 
 
 
 
 
 
 
 
AmerisourceBergen Corporation
AmerisourceBergen Corporation
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust them as their partner in the pharmaceutical supply chain.
year
2019
rev ($mm)
$175,151.50
EBITDA ($mm)
$2,276.42
EBIT ($mm)
$1,735.61
Net Income ($mm)
$929.88
Employees
20500
  • drill down
  • watch
Ticker: ADRX
 
 
 
 
 
 
 
 
Andrx Corporation
Andrx Corporation is committed to providing: high quality, cost effective pharmaceuticals to our customers and to patients; sustained profit and revenue growth to our stockholders; and an employee culture that is stimulating and rewarding.
year
2005
rev ($mm)
$1,145.10
EBITDA ($mm)
$132.00
EBIT ($mm)
$95.90
Net Income ($mm)
$65.70
Employees
0
  • drill down
  • watch
Ticker: MDZ
 
 
 
 
 
 
 
 
MDS, Inc.
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
year
2009
rev ($mm)
$231.00
EBITDA ($mm)
$37.00
EBIT ($mm)
$13.00
Net Income ($mm)
Employees
3600
  • drill down
  • watch
Ticker: ABPI
 
 
 
 
 
 
 
 
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the development of Revimmune as a system of care for the treatment of autoimmune diseases. The company, through its subsidiary, Biovest International, Inc.
year
2012
rev ($mm)
$4.05
EBITDA ($mm)
($11.29)
EBIT ($mm)
($11.54)
Net Income ($mm)
Employees
54
  • drill down
  • watch
Ticker: PFE
 
 
 
 
 
 
 
 
Pfizer, Inc.
Pfizer, Inc.
Pfizer is the world's largest research-based biopharmaceutical company. Pfizer applies science and their global resources to deliver innovative therapies that improve lives. The company has a portfolio of medicines that prevent, treat and cure diseases across a broad range of therapeutic areas.
year
2022
rev ($mm)
$81,288.00
EBITDA ($mm)
$30,793.00
EBIT ($mm)
$25,602.00
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DB:MRK
 
 
 
 
 
 
 
 
Merck KGaA
Merck KGaA
Merck KGaA is a German multinational pharmaceutical, chemical and life sciences company. Merck is the world's oldest operating chemical and pharmaceutical company. The group develops a variety of prescription medicines and specialty chemicals.
year
2019
rev ($mm)
$17,234.26
EBITDA ($mm)
$4,219.33
EBIT ($mm)
$2,268.49
Net Income ($mm)
$3,866.88
Employees
53051
  • drill down
  • watch
Ticker: ENDP
 
 
 
 
 
 
 
 
Endo Health Solutions Inc.
Endo Health Solutions Inc. is a US-based diversified healthcare company that is redefining healthcare value by finding solutions for the unmet needs of patients along care pathways for pain management, pelvic health, urology, endocrinology and oncology.
year
2013
rev ($mm)
$3,027.36
EBITDA ($mm)
$1,075.86
EBIT ($mm)
$790.34
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: LSE:BTG
 
 
 
 
 
 
 
 
BTG International Ltd.
BTG is focused on developing innovative products in specialist areas of medicine to better serve doctors and patients. Their growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins.
year
2016
rev ($mm)
$646.34
EBITDA ($mm)
$150.64
EBIT ($mm)
$89.00
Net Income ($mm)
$28.38
Employees
1370
  • drill down
  • watch
Ticker: PGNX
 
 
 
 
 
 
 
 
Progenics Pharmaceuticals
Progenics Pharmaceuticals
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. They offer a first-in-class PSMA-targeted technology platform for prostate cancer.
year
2015
rev ($mm)
$43.27
EBITDA ($mm)
($0.54)
EBIT ($mm)
($1.07)
Net Income ($mm)
$2.85
Employees
57
  • drill down
  • watch
Ticker: LSE:PRTC
 
 
 
 
 
 
 
 
PureTech Health
PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders and more.
year
2019
rev ($mm)
$9.81
EBITDA ($mm)
($132.05)
EBIT ($mm)
($135.40)
Net Income ($mm)
$421.14
Employees
300
  • drill down
  • watch